Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, and LifeScience Alley, a Minnesota-based trade group, announced plans to create a public-private partnership that will focus on identifying regulatory science tools to assess the safety and efficacy of medical devices. They hope the tools from the collaboration could help streamline the country's regulatory clearance process for devices.

Full Story:

Related Summaries